Korea Personalized Dietary Supplements Market Size & Outlook, 2025-2033
Korea Personalized Dietary Supplements Market Insights
- Based on Deep Market Insights findings, the Korea Personalized Dietary Supplements Market reached USD 105.73 Million in 2024 and is estimated to attain USD 379.72 Million by 2033.
- From 2026 to 2033, the Korea market is expected to grow at a steady CAGR of 15.1%.
- Within the Personalization Method category, DNA Based Plans dominated in 2024 in terms of market size contribution.
- Over the forecast period, DNA Based Plans is forecasted to deliver the fastest growth, positioning it as the most lucrative Personalization Method segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Korea contributed 0.75% to the global Personalized Dietary Supplements Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Personalized Dietary Supplements Market.
- In Asia Pacific, China is projected to capture the leading share of market size by 2033.
- Among Asia Pacific markets, Japan is expected to post the fastest growth, reaching USD 1022.08 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 105.73 Million |
| Market Size In 2033 | USD 379.72 Million |
| Largest segment | DNA Based Plans |
| Units | Revenue in USD Million |
| CAGR | 15.1% (2025-2033) |
| Segmnetation Covered | |
| Personalization Method |
|
| Supplement Type |
|
| Delivery Format |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Korea Personalized Dietary Supplements Market Personalization Method 2025-2033 (USD Million)
| Personalization Method | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA Based Plans | XX.x | XX.x | XX.x | 51.9 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biomarker Analysis | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| App Driven Profiling | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Personalized Dietary Supplements Market Supplement Type 2025-2033 (USD Million)
| Supplement Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitamins | XX.x | XX.x | XX.x | 43.63 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Minerals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Probiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Proteins | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Personalized Dietary Supplements Market Delivery Format 2025-2033 (USD Million)
| Delivery Format | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsules | XX.x | XX.x | XX.x | 47.66 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gummies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.